CBAK ENERGY TECHNOLOGY INC (CBAT)

US14986C1027 - Common Stock

0.812  +0.03 (+4.1%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CBAT. CBAT was compared to 88 industry peers in the Electrical Equipment industry. While CBAT is still in line with the averages on profitability rating, there are concerns on its financial health. CBAT is valued quite cheap, while showing a decent growth score. This is a good combination!



5

1. Profitability

1.1 Basic Checks

CBAT had positive earnings in the past year.
In the past year CBAT had a positive cash flow from operations.
CBAT had negative earnings in 4 of the past 5 years.
In multiple years CBAT reported negative operating cash flow during the last 5 years.

1.2 Ratios

CBAT's Return On Assets of 3.93% is fine compared to the rest of the industry. CBAT outperforms 78.41% of its industry peers.
CBAT has a Return On Equity of 8.79%. This is amongst the best in the industry. CBAT outperforms 81.82% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.02%, CBAT belongs to the top of the industry, outperforming 89.77% of the companies in the same industry.
Industry RankSector Rank
ROA 3.93%
ROE 8.79%
ROIC 11.02%
ROA(3y)6.23%
ROA(5y)0.39%
ROE(3y)11.99%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CBAT has a better Profit Margin (5.56%) than 79.55% of its industry peers.
The Operating Margin of CBAT (11.11%) is better than 79.55% of its industry peers.
Looking at the Gross Margin, with a value of 27.21%, CBAT is in the better half of the industry, outperforming 64.77% of the companies in the same industry.
CBAT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.11%
PM (TTM) 5.56%
GM 27.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.6%
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CBAT is creating some value.
CBAT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CBAT has more shares outstanding
CBAT has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.57, we must say that CBAT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.57, CBAT is in line with its industry, outperforming 51.14% of the companies in the same industry.
CBAT has a debt to FCF ratio of 0.79. This is a very positive value and a sign of high solvency as it would only need 0.79 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.79, CBAT belongs to the top of the industry, outperforming 92.05% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that CBAT is not too dependend on debt financing.
CBAT has a Debt to Equity ratio (0.20) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.79
Altman-Z 0.57
ROIC/WACC1.45
WACC7.62%

2.3 Liquidity

A Current Ratio of 0.85 indicates that CBAT may have some problems paying its short term obligations.
CBAT's Current ratio of 0.85 is on the low side compared to the rest of the industry. CBAT is outperformed by 86.36% of its industry peers.
CBAT has a Quick Ratio of 0.85. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
CBAT has a worse Quick ratio (0.69) than 78.41% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.69

6

3. Growth

3.1 Past

CBAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 254.55%, which is quite impressive.
Looking at the last year, CBAT shows a small growth in Revenue. The Revenue has grown by 2.32% in the last year.
The Revenue has been growing by 52.98% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)254.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-99.71%
Revenue 1Y (TTM)2.32%
Revenue growth 3Y75.84%
Revenue growth 5Y52.98%
Sales Q2Q%-22.68%

3.2 Future

The Earnings Per Share is expected to grow by 91.29% on average over the next years. This is a very strong growth
CBAT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.79% yearly.
EPS Next Y375%
EPS Next 2Y65.83%
EPS Next 3Y91.29%
EPS Next 5YN/A
Revenue Next Year-2.78%
Revenue Next 2Y5.17%
Revenue Next 3Y15.79%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

9

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.78, the valuation of CBAT can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of CBAT indicates a rather cheap valuation: CBAT is cheaper than 98.86% of the companies listed in the same industry.
CBAT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.17.
CBAT is valuated cheaply with a Price/Forward Earnings ratio of 7.24.
97.73% of the companies in the same industry are more expensive than CBAT, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.68, CBAT is valued rather cheaply.
Industry RankSector Rank
PE 4.78
Fwd PE 7.24

4.2 Price Multiples

CBAT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CBAT is cheaper than 100.00% of the companies in the same industry.
CBAT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CBAT is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.14
EV/EBITDA 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CBAT's earnings are expected to grow with 91.29% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y65.83%
EPS Next 3Y91.29%

0

5. Dividend

5.1 Amount

CBAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (12/23/2024, 12:53:52 PM)

0.812

+0.03 (+4.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners2.22%
Inst Owner Change-1.02%
Ins Owners19.83%
Ins Owner Change0%
Market Cap73.02M
Analysts0
Price Target2.04 (151.23%)
Short Float %1.72%
Short Ratio4.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.98%
Min EPS beat(2)-100%
Max EPS beat(2)-1.96%
EPS beat(4)1
Avg EPS beat(4)219.61%
Min EPS beat(4)-198.04%
Max EPS beat(4)1178.43%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-24.84%
Min Revenue beat(2)-25.12%
Max Revenue beat(2)-24.56%
Revenue beat(4)0
Avg Revenue beat(4)-16.06%
Min Revenue beat(4)-25.12%
Max Revenue beat(4)-6.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)600%
EPS NY rev (1m)-38.71%
EPS NY rev (3m)-38.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-25.45%
Revenue NY rev (1m)-9.3%
Revenue NY rev (3m)-9.3%
Valuation
Industry RankSector Rank
PE 4.78
Fwd PE 7.24
P/S 0.35
P/FCF 2.14
P/OCF 1.31
P/B 0.56
P/tB 0.56
EV/EBITDA 1
EPS(TTM)0.17
EY20.94%
EPS(NY)0.11
Fwd EY13.82%
FCF(TTM)0.38
FCFY46.73%
OCF(TTM)0.62
OCFY76.48%
SpS2.31
BVpS1.46
TBVpS1.45
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.93%
ROE 8.79%
ROCE 16.55%
ROIC 11.02%
ROICexc 12.91%
ROICexgc 12.96%
OM 11.11%
PM (TTM) 5.56%
GM 27.21%
FCFM 16.45%
ROA(3y)6.23%
ROA(5y)0.39%
ROE(3y)11.99%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.6%
GM growth 5YN/A
F-Score7
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.79
Debt/EBITDA 0.8
Cap/Depr 224.62%
Cap/Sales 10.47%
Interest Coverage 288.15
Cash Conversion 170.65%
Profit Quality 295.89%
Current Ratio 0.85
Quick Ratio 0.69
Altman-Z 0.57
F-Score7
WACC7.62%
ROIC/WACC1.45
Cap/Depr(3y)352.23%
Cap/Depr(5y)271.45%
Cap/Sales(3y)19.59%
Cap/Sales(5y)17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)254.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-99.71%
EPS Next Y375%
EPS Next 2Y65.83%
EPS Next 3Y91.29%
EPS Next 5YN/A
Revenue 1Y (TTM)2.32%
Revenue growth 3Y75.84%
Revenue growth 5Y52.98%
Sales Q2Q%-22.68%
Revenue Next Year-2.78%
Revenue Next 2Y5.17%
Revenue Next 3Y15.79%
Revenue Next 5YN/A
EBIT growth 1Y1959.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y329.17%
FCF growth 3YN/A
FCF growth 5Y52.56%
OCF growth 1Y183.91%
OCF growth 3YN/A
OCF growth 5Y39.73%